论文部分内容阅读
目的:评价临床路径在门诊处方抗菌药物合理使用中的应用价值。方法:选取2013年3月—2017年3月收治的骨科门诊患者264例,采用随机数字表法将其分为对照组和观察组,每组132例;对照组患者给予采用常规治疗及护理,观察组患者给予采用临床路径展开治疗及护理,比较两组患者治疗后的抗菌药物使用情况以及不合理的原因。结果:观察组患者治疗后选用不当临床路径、无依据更换品种、无指征联用等不合理使用抗菌药物百分率低于对照组(P<0.05),第1代头孢菌素的合理使用率、单用抗菌药物的合理使用率均高于对照组(P<0.05),第3代头孢菌素的合理使用率、二联抗菌药物合理合理使用率和抗菌药物费用均低于对照组(P<0.05);两组患者感染的发生率经组间比较其差异无统计学意义(P>0.05)。结论:采用临床路径实施治疗及护理可规范门诊抗菌药物合理使用,有助于提高门诊抗菌药物使用的合理性、科学性。
Objective: To evaluate the clinical value of clinical pathways in the rational use of prescription antibacterials in outpatients. Methods: Two hundred and sixty-four patients with orthopedic outpatients admitted from March 2013 to March 2017 were selected and randomly divided into control group and observation group with 132 cases in each group. Patients in control group were treated with routine treatment and nursing, Patients in the observation group were given treatment and nursing care using clinical pathways, and the use of antimicrobial agents and the unreasonable causes after treatment were compared between the two groups. Results: The percentage of inappropriate use of antibacterials in the observation group after treatment was lower than that of the control group (P <0.05), the rational use of the first generation cephalosporins, The rational use rate of single antimicrobial agents was higher than that of the control group (P <0.05). The rational use rate of the third generation cephalosporins, reasonably reasonable usage rate of dual antimicrobial agents and the cost of antimicrobial drugs were all lower than those of the control group (P < 0.05). There was no significant difference in the incidence of infection between the two groups (P> 0.05). Conclusion: The clinical path of treatment and care can regulate the rational use of outpatient antibacterial drugs, help to improve the use of outpatient antibacterial drugs rationality and scientific.